Assignee
AADIGEN LLC
US·11 granted patents·10 pending applications·52 citations·filing 2013–2025
Top patents by PatentIndex Score
21 records- 0195US10111965B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2017·Granted Oct 30, 2018·11 cites·20 claims
- 0293US9834581B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2013·Granted Dec 5, 2017·12 cites·12 claims
- 0393US9579395B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2013·Granted Feb 28, 2017·12 cites·28 claims
- 0491US10189876B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2017·Granted Jan 29, 2019·6 cites·16 claims
- 0587US10118944B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2013·Granted Nov 6, 2018·5 cites·21 claims
- 0686US10745440B2Peptides and nanoparticles for intracellular delivery of moleculesAADIGEN LLC·Filed 2015·Granted Aug 18, 2020·2 cites·20 claims
- 0785US11713336B2Peptides and nanoparticles for intracellular delivery of moleculesAADIGEN LLC·Filed 2020·Granted Aug 1, 2023·1 cites·25 claims
- 0883US10688194B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2018·Granted Jun 23, 2020·1 cites·22 claims
- 0977US10287581B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2016·Granted May 14, 2019·1 cites·20 claims
- 1077US2025257342A1Peptides and nanoparticles for intracellular delivery of genome-editing moleculesAADIGEN LLC·Filed 2024·Application pending·0 cites
- 1176US10421784B2Cell penetrating peptides for intracellular delivery of moleculesAADIGEN LLC·Filed 2017·Granted Sep 24, 2019·1 cites·18 claims
- 1271US2025302963A1Peptides and nanoparticles for intracellular delivery of moleculesAADIGEN LLC·Filed 2025·Application pending·0 cites
- 1366US12357695B2Peptides and nanoparticles for intracellular delivery of moleculesAADIGEN LLC·Filed 2020·Granted Jul 15, 2025·0 cites·25 claims
- 1463US2020332300A1Multi-target modulation for treating fibrosis and inflammatory conditionsAADIGEN LLC·Filed 2020·Application pending·0 cites
- 1560US2023304010A1Compositions and methods for treating viral infectionsAADIGEN LLC·Filed 2021·Application pending·0 cites
- 1659US2023167437A1Compositions for treating cancer with kras mutations and uses thereofAADIGEN LLC·Filed 2021·Application pending·0 cites
- 1755US2015080320A1Multi-target modulation for treating fibrosis and inflammatory conditionsAADIGEN LLC·Filed 2013·Application pending·0 cites
- 1854US2018187199A1Multi-target modulation for treating fibrosis and inflammatory conditionsAADIGEN LLC·Filed 2017·Application pending·0 cites
- 1952US2019211317A1Peptides and nanoparticles for intracellular delivery of genome-editing moleculesAADIGEN LLC·Filed 2017·Application pending·0 cites
- 2049US2020172913A1Peptides and nanoparticles for intracellular delivery of virusAADIGEN LLC·Filed 2018·Application pending·0 cites
- 2144US2020323964A1Peptides and nanoparticles for intracellular delivery of mrnaAADIGEN LLC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →